Zhitong Finance App News, Sanai Health Group (01889) announced that compared with the same period in 2022, it is expected that the group's revenue and gross margin will be drastically reduced in 2023, resulting in a significant reduction of no more than 40% in net profit attributable to company owners.

According to the announcement, the sharp decline in revenue and gross margin was mainly due to a decrease in sales of home-produced pharmaceutical products and a sharp rise in the overall cost of traditional Chinese herbal medicines during the reporting period.